These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26900655)

  • 41. Virtual screening, SAR, and discovery of 5-(indole-3-yl)-2-[(2-nitrophenyl)amino] [1,3,4]-oxadiazole as a novel Bcl-2 inhibitor.
    Ziedan NI; Hamdy R; Cavaliere A; Kourti M; Prencipe F; Brancale A; Jones AT; Westwell AD
    Chem Biol Drug Des; 2017 Jul; 90(1):147-155. PubMed ID: 28067996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
    Du K; Cao X; Zhang P; Zheng H
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
    Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
    Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.
    Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and biological evaluation of novel carbamodithioates as anti-proliferative agents against human cancer cells.
    Liu X; Wang Z; Xie R; Tang P; Yuan Q
    Eur J Med Chem; 2018 Sep; 157():1526-1540. PubMed ID: 30282324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
    Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
    Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
    El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
    Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.
    Patel NB; Purohit AC; Rajani DP; Moo-Puc R; Rivera G
    Eur J Med Chem; 2013 Apr; 62():677-87. PubMed ID: 23434641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.
    Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA
    Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
    Alam MS; Nam YJ; Lee DU
    Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents.
    Li RD; Wang HL; Li YB; Wang ZQ; Wang X; Wang YT; Ge ZM; Li RT
    Eur J Med Chem; 2015 Mar; 93():381-91. PubMed ID: 25725374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
    Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
    Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy.
    Shamsi F; Hasan P; Queen A; Hussain A; Khan P; Zeya B; King HM; Rana S; Garrison J; Alajmi MF; Rizvi MMA; Zahid M; Imtaiyaz Hassan M; Abid M
    Bioorg Chem; 2020 May; 98():103754. PubMed ID: 32200329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
    Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and anticancer activity of new dihydropyrimidinone derivatives.
    Mostafa AS; Selim KB
    Eur J Med Chem; 2018 Aug; 156():304-315. PubMed ID: 30015070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines.
    Li RD; Zhang X; Li QY; Ge ZM; Li RT
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3637-40. PubMed ID: 21570843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
    Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
    Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.